Skip to content
Branschnyheter· News

Neko Health raises SEK 200m in new funding round

Health tech company Neko Health, led by CEO Hjalmar Nilsonne, has secured a further major funding round of SEK 200 million.

By the Aheadline editorial team·15 juli 2026·2 min read·Source: BreakitVerifierad signalAI-generated
Neko Health raises SEK 200m in new funding round
Neko Health raises SEK 200m in new funding round
Neko Health raises SEK 200m in new funding round
By · Policy- & EU-reporter

What happened?

Neko Health has secured SEK 200 million in a new funding round. The company is now valued at approximately SEK 1.2 billion following total capital injections of SEK 300 million. The investment establishes Neko Health as one of Sweden's highest-valued tech companies within the healthcare sector.

Key facts

Finansieringsbelopp200 MSEK
Totalt insamlat kapital300 MSEK
Antal skanningar hittillsÖver 100 000
Värdering (post-money)Ca 1,2 miljarder SEK
MålsättningNå miljontals användare

Det finns möjlighet att bli ett av världens viktigaste företag.

Hjalmar Nilsonne, vd · Breakit

Why it matters

The new funding enables Neko Health to continue its expansion and the development of its body scanning technologies. The goal is to increase the number of scans from over 100,000 to millions, potentially reshaping preventive healthcare through early disease detection. The significant investment confirms market interest in the company's business model.

Who is affected?

The funding round primarily impacts Neko Health's management, employees, and investors. Medical technology and AI developers may also be affected by increased competition and innovation in the field. Users of Neko Health's services in Sweden and other expansion markets will gain access to their preventive health check-ups.

Impact on the EU

Founded in Sweden, Neko Health is available within the EU. Its expansion and growth allow more EU citizens to access preventive healthcare services. Relevant to its EU status, medical devices and services within the EEA must comply with strict EU regulations, such as the Medical Device Regulation (MDR) and GDPR for data protection.

What else you should know

The founders are Hjalmar Nilsonne and Daniel Ek.

Frequently asked questions

Quick answers about this story

Vad har hänt?
Neko Health, ett svenskt hälsovårdsbolag, har säkrat 200 miljoner kronor i en ny finansieringsrunda. Detta ökar bolagets totala insamlade kapital till 300 miljoner kronor och värderar företaget till cirka 1,2 miljarder kronor.
När hände det?
Informationen om den nya finansieringsrundan offentliggjordes den 20 maj 2024.
Varför spelar det roll?
Finansieringen gör Neko Health till ett av Sveriges högst värderade techbolag och möjliggör en stor expansion av deras förebyggande hälsokontroller. Målet är att revolutionera hälsovården genom tidig upptäckt av sjukdomar för miljontals användare, vilket kan leda till förbättrad folkhälsa och minskade vårdkostnader på sikt.
Vilka bolag berörs?
Neko Health är det primärt berörda bolaget. Investerare i denna runda samt konkurrenter inom medicinteknik och preventiv hälsovård påverkas också indirekt.
Original source
Breakit·breakit.se

The link opens in a new window and leads to the publisher's own site.

Verifierad signal

Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.

AI-verktyg i artikeln

Topics

#Sverige#Medicinsk AI#AI-startups#Startup
[ STAY UP TO DATE ]

Get similar news straight to your inbox

No affiliate linksCancel anytimeGDPR-friendly
[ Frequency ]
[ What do you want to read about? ]

You'll receive updates on 2 topics.

The reader's room

Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.

Sign in to submit a comment or question.

Loading comments…
How this affects you

Read the article through your role

  • Where does a window open: market, tech, distribution or pricing?
  • What can you test in under two weeks without burning capital?
  • Who do you need to talk to this week to validate the assumption?

Generated angle — not editorial analysis of "Neko Health raises SEK 200m in new funding round"